scholarly journals CHARACTERISTIC OF PEDIATRIC UROLITHIASIS PATIENTS IN ZAINOEL ABIDIN HOSPITAL

2018 ◽  
Vol 25 (1) ◽  
Author(s):  
Simon Natanel Yohanes ◽  
Dahril Dahril

Objective: We conducted a study to describe the characteristics of pediatric urolithiasis patients in Zainoel Abidin Hospital, Aceh-Indonesia. Material & Methods: Between January 2013 and March 2016, we retrospectively reviewed the medical records of 16 pediatric patients with urolithiasis in Zainoel Abidin Hospital, Aceh-Indonesia. The patients were come from whole Aceh region and the variables are sex, age, family history of stone disease, and stone location. The data were described in graphics and tables. Results: From 16 pediatric urolithiasis patients, 9 patients (56.3%) were males and 7 patients (43.7%) were females. In 2013 there were 4 pediatric urolithiasis patients (1.2%), in 2014 there were 5 (1.6%), and in 2015 there were 3 (2.3%). From January – March 2016 there were 4 pediatric urolithiasis patients (4.5% of all urolithiasis patients). The mean age of all pediatric patients were 7.7 ± 5.5 years (1-17 years). The incidence of urolithiasis for group < 5 years of age were 6 patients (37.5%) with mean age of 2 ± 1.14 years (1-4 years), in 5–10 years age group, there were 4 patients (25.0%) with mean age 7 ± 2.16 years (5-10 years), and 11–18 years age group, there were 6 patients (37.5%) with mean age 13.8 ± 2.16 years (12-16 years). Stones were located in the upper urinary tract in 9 cases (56.3%), lower urinary tract in 6 cases (37.5%), and combine stone located in upper and lower urinary tract in 1 case (6.2%). There were 5 patients (31.3%) with family history of stone disease. Conclusion: Pediatric urolithiasis case in Aceh Province is slightly predominant in male children, with mean age of 7.7 ± 5.5 years (1-16 years). The most common age group is evenly distribute between <5 years old and 11-18 years old. The most common stone location is in the upper urinary tract.

2020 ◽  
Vol 13 (12) ◽  
pp. e236280
Author(s):  
Ayesha Nusrat ◽  
Syed Muhammad Nazim

Malignant lymphomas of the prostate are very rare tumours and are generally not considered in the clinical or pathological diagnosis of prostatic enlargement. We report a case of a 56-year-old man who presented with long-standing history of low back pain and a 2-month history of voiding lower urinary tract symptoms. He denied any history of urinary retention, trauma, catheterisation or any constitutional symptoms. Examination revealed no lymphadenopathy and hepatosplenomegaly. Digital rectal examination showed an irregular, moderately enlarged nodular prostate. His prostate-specific antigen was 1.54 ng/mL. MRI of the pelvis did not show any focal lesion apart from abnormal signal intensity in the central zone. Bone scan was negative. Transrectal ultrasound-guided prostate biopsy revealed diffuse large B cell lymphoma. Bone marrow biopsy and whole body positron emission tomography/CT were unremarkable. The patient achieved complete remission after receiving six cycles of R-CHOP chemotherapy.


2018 ◽  
Vol 315 (5) ◽  
pp. F1422-F1429 ◽  
Author(s):  
Warren G. Hill ◽  
Mark L. Zeidel ◽  
Dale E. Bjorling ◽  
Chad M. Vezina

Investigators have for decades used mouse voiding patterns as end points for studying behavioral biology. It is only recently that mouse voiding patterns were adopted for study of lower urinary tract physiology. The spontaneous void spot assay (VSA), a popular micturition assessment tool, involves placing a mouse in an enclosure lined by filter paper and quantifying the resulting urine spot pattern. The VSA has advantages of being inexpensive and noninvasive, but some investigators challenge its ability to distinguish lower urinary tract function from behavioral voiding. A consensus group of investigators who regularly use the VSA was established by the National Institutes of Health in 2015 to address the strengths and weaknesses of the assay, determine whether it can be standardized across laboratories, and determine whether it can be used as a surrogate for evaluating urinary function. Here we leverage experience from the consensus group to review the history of the VSA and its uses, summarize experiments to optimize assay design for urinary physiology assessment, and make best practice recommendations for performing the assay and analyzing its results.


2021 ◽  
pp. 677-682
Author(s):  
Noah E. Canvasser ◽  
Jennifer G. Rothschild ◽  
Frederick J. Meyers ◽  
Christopher P. Evans

Both upper and lower urinary tract obstruction are prevalent in the palliative care setting. Although sometimes related to urological conditions, non-urological aetiologies are also seen. Common causes of lower urinary tract obstruction include benign prostatic hyperplasia in men, an underlying neurological condition, and advanced pelvic malignancy. In the acute setting, bladder decompression with a Foley catheter is the easiest and fastest way to resolve the problem. Common causes of upper urinary tract obstruction include nephrolithiasis and advanced malignancy. This chapter will address the evaluation and management of these common clinical issues.


2016 ◽  
Vol 22 (11) ◽  
pp. 1490-1494 ◽  
Author(s):  
Jeroen R Scheepe ◽  
Yu Yi M Wong ◽  
E Daniëlle van Pelt ◽  
Immy A Ketelslegers ◽  
Coriene E Catsman-Berrevoets ◽  
...  

Neurogenic lower urinary tract dysfunction (LUTD) in multiple sclerosis (MS) is highly prevalent in adults, but has not previously been described in paediatric MS. A total of 24 consecutive children with newly diagnosed MS were prospectively assessed for bladder and bowel problems early after diagnosis. Five of 24 children (21%) showed LUTD during assessment. One of these patients did not report voiding complaints. This high prevalence of LUTD indicates that all recently diagnosed patients with paediatric MS should be evaluated early in their disease and treated for urinary problems in order to prevent potential damage to the upper urinary tract.


Author(s):  
Richard J Bryant ◽  
James W Catto

Haematuria is the presence of blood within the urine and is best defined as visible or non-visible, and symptomatic or non-symptomatic. Non-visible haematuria may be further classified as microscopic or dipstick, depending on the investigation used to detect it. Around 40% of patients presenting with visible haematuria will be found to have a significant underlying cause, and around 20% of patients will be found to have an underlying urological malignancy. Many younger patients will be found to have an underlying nephrological disease. The risk of significant underlying malignancy increases with the extent of haematuria (visible versus non-visible), the absence of symptoms and various patient factors (such as rising age, smoking status, and gender). As such, haematuria is an important urological symptom that requires investigation. These investigations should include clinical assessment, urinalysis, lower urinary tract endoscopy, and upper urinary tract radiological evaluation.


2011 ◽  
Vol 26 (4) ◽  
pp. 571-577 ◽  
Author(s):  
Marcos Lopes ◽  
Alexandre Ferraro ◽  
Ulysses Dória Filho ◽  
Evelyn Kuckzinski ◽  
Vera H. Koch

2008 ◽  
Vol 179 (4S) ◽  
pp. 411-411
Author(s):  
Eduardo Ruiz ◽  
Juan Moldes ◽  
Javier Escalante Cateriano ◽  
Francisco de Badiola ◽  
Carlos Giuseppucci ◽  
...  

2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
M Breish ◽  
C Harding ◽  
S Biswas

Abstract Aim Urodynamic studies (UDS) are physiological measurements of voiding and storage function of the lower urinary tract that are commonly performed in clinical practice to investigate bothersome lower urinary tract symptoms. Despite considerable efforts to improve UDS, standardisation of the practice remains to be challenging. This audit thus, presents a review the current UDS referral process and analysis of the clinical details included on urodynamic requests. Method This audit included retrospective data from 112 patients between March and Oct 2020, 98 of which had UDS performed. Patient electronic records, referral forms and clinic letters were all used for data collection. Results Data shows that 47% of patients were females with average age of 56 years, range (16-86) years. The reason of UDS was clearly stated in 8 referrals only and the clinical examination findings were clearly mentioned in 31% only. More than three quarters of patients (i.e., 77%) had assessment of post void residual prior to UDS, but half of the proportion had no history of relevant medications. In 98 patients who had UDS done, the main findings showed that 4 patients had normal studies, 3 with dysfunctional voiding, 7 had bladder outflow obstruction, 32 patients were diagnosed with detrusor overactivity, 12 had stress incontinence and 7 showed detrusor underactivity. Conclusions Finding of this audit clearly suggest a level of unclarity in the great majority of referrals. Evidently, key history of relevant medication is overlooked in half of the referrals. Improvements to the current pathway to UDS is therefore pivotal.


Sign in / Sign up

Export Citation Format

Share Document